Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00773812
Recruitment Status : Completed
First Posted : October 16, 2008
Last Update Posted : January 13, 2017
Autism Speaks
Information provided by (Responsible Party):
L. Eugene Arnold, Ohio State University